跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aritero 5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aritero 5
Approved
STANDARD
Aritero 5
Hetero Labs Limited (Unit V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b7cce05db03112f6
Company
Hetero Labs Limited (Unit V)
Type
Standard
Approval Details
Approval Id
b7cce05db03112f6
Drug Approval Philippines Name
Aritero 5
Product Name
Aritero 5
Registration Number
DRP-16485
Brand Name
Aritero 5
Generic Name
Aripiprazole
Dosage Form
Tablet
Dosage Strength
5mg
Manufacturer
Hetero Labs Limited (Unit V)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
26 March 2025
Expiry Date
25 March 2030
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b7cce05db03112f6
Type
Standard
Back to Philippines FDA Approvals